SIMILAR PATTERNS OF AMINO ACIDS FOR 4QRC_A_0LIA802_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b06 PROTEIN (SUPEROXIDE
DISMUTASE)

(Sulfolobus
acidocaldarius) 		PF00081
(Sod_Fe_N)
PF02777
(Sod_Fe_C) 		4 LEU A   6
LYS A  54
ILE A  70
LEU A  74
 None
 0.86A 4qrcA-1b06A:
undetectable		 4qrcA-1b06A:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bh6 SUBTILISIN DY

(Bacillus
licheniformis) 		PF00082
(Peptidase_S8) 		5 LEU A 233
VAL A  84
ILE A 268
ALA A 273
LEU A 250
 None
 1.27A 4qrcA-1bh6A:
undetectable		 4qrcA-1bh6A:
21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dhs DEOXYHYPUSINE
SYNTHASE

(Homo sapiens) 		PF01916
(DS) 		5 LEU A 350
VAL A 351
ILE A 112
ALA A 343
LEU A 281
 None
None
None
NAD  A 700 (-3.6A)
None
 1.14A 4qrcA-1dhsA:
undetectable		 4qrcA-1dhsA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fc4 2-AMINO-3-KETOBUTYRA
TE CONENZYME A
LIGASE

(Escherichia
coli) 		PF00155
(Aminotran_1_2) 		4 LEU A 394
ILE A 367
ALA A 338
LEU A 332
 None
 0.84A 4qrcA-1fc4A:
undetectable		 4qrcA-1fc4A:
21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gns SUBTILISIN BPN'

(Bacillus
amyloliquefaciens) 		PF00082
(Peptidase_S8) 		5 LEU A 233
VAL A  84
ILE A 268
ALA A 273
LEU A 250
 None
 1.28A 4qrcA-1gnsA:
undetectable		 4qrcA-1gnsA:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gom ENDO-1,4-BETA-XYLANA
SE

(Thermoascus
aurantiacus) 		PF00331
(Glyco_hydro_10) 		4 VAL A 258
ILE A 204
ALA A 228
ARG A 124
 None
 0.81A 4qrcA-1gomA:
undetectable		 4qrcA-1gomA:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gzk RAC-BETA
SERINE/THREONINE
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		4 LEU A 158
VAL A 166
LYS A 181
ALA A 232
 None
 0.85A 4qrcA-1gzkA:
22.2		 4qrcA-1gzkA:
25.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h1y D-RIBULOSE-5-PHOSPHA
TE 3-EPIMERASE

(Oryza sativa) 		PF00834
(Ribul_P_3_epim) 		4 VAL A 163
ILE A 197
HIS A  36
LEU A 181
 None
 0.78A 4qrcA-1h1yA:
undetectable		 4qrcA-1h1yA:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i7o 4-HYDROXYPHENYLACETA
TE DEGRADATION
BIFUNCTIONAL
ISOMERASE/DECARBOXYL
ASE

(Escherichia
coli) 		PF01557
(FAA_hydrolase) 		4 VAL A  77
ILE A  86
ALA A 153
LEU A  68
 None
 0.80A 4qrcA-1i7oA:
undetectable		 4qrcA-1i7oA:
23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jwa MOLYBDOPTERIN
BIOSYNTHESIS MOEB
PROTEIN

(Escherichia
coli) 		PF00899
(ThiF) 		5 LEU B  58
VAL B  34
ILE B 209
ALA B  53
LEU B  29
 None
 1.44A 4qrcA-1jwaB:
undetectable		 4qrcA-1jwaB:
21.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1k2p TYROSINE-PROTEIN
KINASE BTK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 408
VAL A 416
LYS A 430
HIS A 519
LEU A 528
 None
 1.08A 4qrcA-1k2pA:
27.9		 4qrcA-1k2pA:
33.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1krt LYSYL-TRNA
SYNTHETASE (PRODUCT
OF LYSS GENE)

(Escherichia
coli) 		PF01336
(tRNA_anti-codon) 		4 LEU A  97
VAL A  86
ALA A 124
LEU A 143
 None
 0.85A 4qrcA-1krtA:
undetectable		 4qrcA-1krtA:
19.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1luf MUSCLE-SPECIFIC
TYROSINE KINASE
RECEPTOR MUSK

(Rattus
norvegicus) 		PF07714
(Pkinase_Tyr) 		4 VAL A 588
LYS A 608
HIS A 722
LEU A 731
 None
 0.72A 4qrcA-1lufA:
34.2		 4qrcA-1lufA:
40.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n4d VITAMIN B12
TRANSPORT PROTEIN
BTUF

(Escherichia
coli) 		PF01497
(Peripla_BP_2) 		4 VAL A 160
LYS A 125
ILE A 230
ALA A 232
 None
 0.77A 4qrcA-1n4dA:
undetectable		 4qrcA-1n4dA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nxk MAP KINASE-ACTIVATED
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  70
VAL A  78
LYS A  93
LEU A 193
 STU  A 401 (-3.9A)
STU  A 401 (-4.7A)
STU  A 401 ( 4.5A)
STU  A 401 (-4.7A)
 0.61A 4qrcA-1nxkA:
19.7		 4qrcA-1nxkA:
25.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1obb ALPHA-GLUCOSIDASE

(Thermotoga
maritima) 		PF02056
(Glyco_hydro_4)
PF11975
(Glyco_hydro_4C) 		4 LEU A  20
ILE A  48
ALA A  11
LEU A  37
 None
 0.79A 4qrcA-1obbA:
undetectable		 4qrcA-1obbA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1opk PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1

(Mus musculus) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		5 LEU A 267
VAL A 275
LYS A 290
HIS A 380
LEU A 389
 P16  A   2 ( 4.2A)
P16  A   2 (-4.5A)
P16  A   2 (-4.5A)
None
P16  A   2 (-4.4A)
 0.48A 4qrcA-1opkA:
30.7		 4qrcA-1opkA:
29.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1prx HORF6

(Homo sapiens) 		PF00578
(AhpC-TSA)
PF10417
(1-cysPrx_C) 		4 LEU A 161
ALA A  58
HIS A  39
ARG A 132
 None
None
CSO  A  47 ( 3.9A)
CSO  A  47 ( 4.7A)
 0.84A 4qrcA-1prxA:
undetectable		 4qrcA-1prxA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q8y SR PROTEIN KINASE

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		4 LEU A 164
VAL A 172
HIS A 292
LEU A 301
 ADP  A 810 ( 4.3A)
ADP  A 810 (-4.1A)
None
ADP  A 810 (-4.7A)
 0.64A 4qrcA-1q8yA:
21.4		 4qrcA-1q8yA:
24.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qwj CYTIDINE
MONOPHOSPHO-N-ACETYL
NEURAMINIC ACID
SYNTHETASE

(Mus musculus) 		PF02348
(CTP_transf_3) 		4 VAL A 155
ILE A 140
ALA A  76
LEU A 147
 None
 0.70A 4qrcA-1qwjA:
undetectable		 4qrcA-1qwjA:
19.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1rjb FL CYTOKINE RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU A 616
VAL A 624
HIS A 809
LEU A 818
 None
 0.37A 4qrcA-1rjbA:
33.7		 4qrcA-1rjbA:
43.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rt8 FIMBRIN

(Schizosaccharomyces
pombe) 		PF00307
(CH) 		5 LEU A 467
VAL A 457
ALA A 485
LEU A 482
ARG A 446
 None
 1.49A 4qrcA-1rt8A:
undetectable		 4qrcA-1rt8A:
19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s9i DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  78
VAL A  86
HIS A 192
LEU A 201
 ATP  A 535 (-3.9A)
ATP  A 535 (-4.1A)
None
ATP  A 535 (-4.8A)
 0.61A 4qrcA-1s9iA:
16.5		 4qrcA-1s9iA:
26.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1scj SUBTILISIN E

(Bacillus
subtilis) 		PF00082
(Peptidase_S8) 		5 LEU A 233
VAL A  84
ILE A 268
ALA A 273
LEU A 250
 None
 1.32A 4qrcA-1scjA:
undetectable		 4qrcA-1scjA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1smk MALATE
DEHYDROGENASE,
GLYOXYSOMAL

(Citrullus
lanatus) 		PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C) 		4 LEU A 205
VAL A 204
ILE A 243
LEU A 229
 None
 0.85A 4qrcA-1smkA:
undetectable		 4qrcA-1smkA:
23.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1snx TYROSINE-PROTEIN
KINASE ITK/TSK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 VAL A 377
LYS A 391
HIS A 480
LEU A 489
 None
 0.83A 4qrcA-1snxA:
29.7		 4qrcA-1snxA:
31.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sny SNIFFER CG10964-PA

(Drosophila
melanogaster) 		PF00106
(adh_short) 		4 LEU A  16
VAL A  19
ILE A  57
ALA A  42
 None
 0.71A 4qrcA-1snyA:
undetectable		 4qrcA-1snyA:
23.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1t46 HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU A 595
VAL A 603
HIS A 790
LEU A 799
 STI  A   3 ( 3.8A)
STI  A   3 ( 4.6A)
STI  A   3 (-4.5A)
STI  A   3 (-4.4A)
 0.25A 4qrcA-1t46A:
35.2		 4qrcA-1t46A:
48.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1te2 2-DEOXYGLUCOSE-6-P
PHOSPHATASE

(Escherichia
coli) 		PF13419
(HAD_2) 		5 LEU A 161
VAL A 163
ILE A   7
ALA A  10
LEU A 109
 None
 1.18A 4qrcA-1te2A:
undetectable		 4qrcA-1te2A:
23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tqx D-RIBULOSE-5-PHOSPHA
TE 3-EPIMERASE,
PUTATIVE

(Plasmodium
falciparum) 		PF00834
(Ribul_P_3_epim) 		4 VAL A 164
ILE A 198
HIS A  36
LEU A 182
 None
None
ZN  A 900 (-3.4A)
None
 0.85A 4qrcA-1tqxA:
undetectable		 4qrcA-1tqxA:
20.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1u59 TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 LEU A 344
VAL A 352
LYS A 369
ALA A 417
HIS A 459
LEU A 468
 STU  A 100 (-3.8A)
STU  A 100 (-4.8A)
STU  A 100 ( 4.7A)
STU  A 100 (-3.7A)
None
STU  A 100 (-4.5A)
 0.59A 4qrcA-1u59A:
30.6		 4qrcA-1u59A:
35.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u5q SERINE/THREONINE
PROTEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		5 VAL A  42
LYS A  57
ILE A  89
HIS A 149
LEU A 158
 None
 0.59A 4qrcA-1u5qA:
24.5		 4qrcA-1u5qA:
28.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ul1 FLAP ENDONUCLEASE-1

(Homo sapiens) 		PF00752
(XPG_N)
PF00867
(XPG_I) 		5 LEU X 263
ILE X 250
ALA X 246
HIS X 280
LEU X 229
 None
 1.30A 4qrcA-1ul1X:
undetectable		 4qrcA-1ul1X:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1un9 DIHYDROXYACETONE
KINASE

(Citrobacter
freundii) 		PF02733
(Dak1)
PF02734
(Dak2) 		4 LEU A 244
VAL A 241
ILE A 285
LEU A 254
 None
 0.72A 4qrcA-1un9A:
undetectable		 4qrcA-1un9A:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v0b CELL DIVISION
CONTROL PROTEIN 2
HOMOLOG

(Plasmodium
falciparum) 		PF00069
(Pkinase) 		4 VAL A  18
LYS A  32
HIS A 123
LEU A 132
 None
 0.74A 4qrcA-1v0bA:
22.0		 4qrcA-1v0bA:
25.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v31 HYPOTHETICAL PROTEIN
RAFL11-05-P19

(Arabidopsis
thaliana) 		PF02201
(SWIB) 		5 LEU A  60
VAL A  63
ILE A  32
ALA A  35
LEU A  22
 None
 1.32A 4qrcA-1v31A:
undetectable		 4qrcA-1v31A:
15.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v8d HYPOTHETICAL PROTEIN
(TT1679)

(Thermus
thermophilus) 		PF04260
(DUF436) 		4 LEU A 119
VAL A 160
ALA A 167
LEU A  65
 None
 0.86A 4qrcA-1v8dA:
undetectable		 4qrcA-1v8dA:
21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wer P120GAP

(Homo sapiens) 		PF00616
(RasGAP) 		5 LEU A 930
VAL A 933
ILE A 905
ALA A 908
LEU A 814
 None
 1.44A 4qrcA-1werA:
undetectable		 4qrcA-1werA:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yul PROBABLE
NICOTINATE-NUCLEOTID
E
ADENYLYLTRANSFERASE

(Pseudomonas
aeruginosa) 		PF01467
(CTP_transf_like) 		4 LEU A 105
VAL A 130
ALA A  27
LEU A  32
 None
 0.76A 4qrcA-1yulA:
undetectable		 4qrcA-1yulA:
25.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zlt SERINE/THREONINE-PRO
TEIN KINASE CHK1

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  15
VAL A  23
HIS A 128
LEU A 137
 HYM  A 400 (-4.2A)
HYM  A 400 (-4.3A)
None
HYM  A 400 (-4.5A)
 0.53A 4qrcA-1zltA:
21.8		 4qrcA-1zltA:
27.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zy4 SERINE/THREONINE-PRO
TEIN KINASE GCN2

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		4 LEU A 605
VAL A 613
LYS A 628
HIS A 833
 None
 0.82A 4qrcA-1zy4A:
21.4		 4qrcA-1zy4A:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2aaz THYMIDYLATE SYNTHASE

(Cryptococcus
neoformans) 		PF00303
(Thymidylat_synt) 		4 LEU A 280
VAL A 302
ALA A 232
HIS A  18
 None
 0.83A 4qrcA-2aazA:
undetectable		 4qrcA-2aazA:
23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ac5 MAP
KINASE-INTERACTING
SERINE/THREONINE
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		4 VAL A  98
LYS A 113
HIS A 203
LEU A 212
 None
 0.71A 4qrcA-2ac5A:
19.5		 4qrcA-2ac5A:
24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bdw HYPOTHETICAL PROTEIN
K11E8.1D

(Caenorhabditis
elegans) 		PF00069
(Pkinase) 		4 VAL A 152
ILE A 116
ALA A 112
LEU A 206
 None
 0.81A 4qrcA-2bdwA:
7.7		 4qrcA-2bdwA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2buj SERINE/THREONINE-PRO
TEIN KINASE 16

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  26
VAL A  34
LYS A  49
LEU A 155
 STU  A1301 (-4.2A)
STU  A1301 (-4.8A)
STU  A1301 ( 4.0A)
STU  A1301 ( 4.8A)
 0.86A 4qrcA-2bujA:
23.0		 4qrcA-2bujA:
25.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2buj SERINE/THREONINE-PRO
TEIN KINASE 16

(Homo sapiens) 		PF00069
(Pkinase) 		4 VAL A  34
LYS A  49
HIS A 146
LEU A 155
 STU  A1301 (-4.8A)
STU  A1301 ( 4.0A)
None
STU  A1301 ( 4.8A)
 0.84A 4qrcA-2bujA:
23.0		 4qrcA-2bujA:
25.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c9a RECEPTOR-TYPE
TYROSINE-PROTEIN
PHOSPHATASE MU

(Homo sapiens) 		PF00047
(ig)
PF00629
(MAM) 		4 LEU A 276
VAL A 194
ALA A 228
LEU A 220
 None
 0.81A 4qrcA-2c9aA:
undetectable		 4qrcA-2c9aA:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cqz 177AA LONG
HYPOTHETICAL PROTEIN

(Pyrococcus
horikoshii) 		PF13023
(HD_3) 		4 LEU A 166
VAL A 169
ILE A  40
LEU A  44
 None
 0.86A 4qrcA-2cqzA:
undetectable		 4qrcA-2cqzA:
19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cy8 D-PHENYLGLYCINE
AMINOTRANSFERASE

(Pseudomonas
stutzeri) 		PF00202
(Aminotran_3) 		4 LEU A 290
VAL A 289
ALA A 129
LEU A 264
 None
 0.81A 4qrcA-2cy8A:
undetectable		 4qrcA-2cy8A:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dkj SERINE
HYDROXYMETHYLTRANSFE
RASE

(Thermus
thermophilus) 		PF00464
(SHMT) 		4 LEU A  28
VAL A 339
ALA A 378
LEU A 297
 None
 0.83A 4qrcA-2dkjA:
undetectable		 4qrcA-2dkjA:
23.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dlc TYROSYL-TRNA
SYNTHETASE,
CYTOPLASMIC

(Saccharomyces
cerevisiae) 		PF00579
(tRNA-synt_1b) 		4 LEU X 266
VAL X 269
ALA X 311
LEU X 317
 None
 0.85A 4qrcA-2dlcX:
undetectable		 4qrcA-2dlcX:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dn4 GENERAL
TRANSCRIPTION FACTOR
II-I

(Homo sapiens) 		PF02946
(GTF2I) 		4 LEU A  15
VAL A  12
ILE A  53
LEU A  49
 None
 0.79A 4qrcA-2dn4A:
undetectable		 4qrcA-2dn4A:
15.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU X  17
VAL X  25
HIS X 128
LEU X 137
 STU  X 902 (-3.8A)
STU  X 902 ( 4.8A)
None
STU  X 902 (-4.4A)
 0.45A 4qrcA-2dq7X:
31.7		 4qrcA-2dq7X:
34.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU X  17
VAL X  25
LYS X  39
LEU X 137
 STU  X 902 (-3.8A)
STU  X 902 ( 4.8A)
STU  X 902 (-3.1A)
STU  X 902 (-4.4A)
 0.70A 4qrcA-2dq7X:
31.7		 4qrcA-2dq7X:
34.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dzq GENERAL
TRANSCRIPTION FACTOR
II-I REPEAT
DOMAIN-CONTAINING
PROTEIN 1

(Homo sapiens) 		PF02946
(GTF2I) 		4 LEU A  15
VAL A  12
ILE A  53
LEU A  49
 None
 0.67A 4qrcA-2dzqA:
undetectable		 4qrcA-2dzqA:
13.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dzr GENERAL
TRANSCRIPTION FACTOR
II-I REPEAT
DOMAIN-CONTAINING
PROTEIN 1

(Homo sapiens) 		PF02946
(GTF2I) 		4 LEU A  15
VAL A  12
ILE A  53
LEU A  49
 None
 0.79A 4qrcA-2dzrA:
undetectable		 4qrcA-2dzrA:
18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eu9 DUAL SPECIFICITY
PROTEIN KINASE CLK3

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A 162
VAL A 170
LYS A 186
HIS A 281
LEU A 290
 None
 1.02A 4qrcA-2eu9A:
7.7		 4qrcA-2eu9A:
26.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f9g MITOGEN-ACTIVATED
PROTEIN KINASE FUS3

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		5 LEU A  19
VAL A  27
ILE A  72
HIS A 135
LEU A 144
 ADP  A 500 (-4.3A)
ADP  A 500 (-4.3A)
None
None
ADP  A 500 (-4.3A)
 0.58A 4qrcA-2f9gA:
22.3		 4qrcA-2f9gA:
25.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g5g PUTATIVE LIPOPROTEIN

(Campylobacter
jejuni) 		PF04187
(Cofac_haem_bdg) 		4 LEU X  44
VAL X 243
ILE X  33
LEU X  64
 None
 0.63A 4qrcA-2g5gX:
undetectable		 4qrcA-2g5gX:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gcd SERINE/THREONINE-PRO
TEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		5 VAL A  42
LYS A  57
ILE A  89
HIS A 149
LEU A 158
 STU  A 400 ( 4.8A)
STU  A 400 ( 4.5A)
STU  A 400 ( 4.5A)
None
STU  A 400 ( 4.6A)
 0.43A 4qrcA-2gcdA:
25.4		 4qrcA-2gcdA:
28.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gwr DNA-BINDING RESPONSE
REGULATOR MTRA

(Mycobacterium
tuberculosis) 		PF00072
(Response_reg)
PF00486
(Trans_reg_C) 		5 LEU A  71
VAL A  67
ILE A  35
ALA A  44
LEU A   9
 None
 1.27A 4qrcA-2gwrA:
undetectable		 4qrcA-2gwrA:
23.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h8h PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		4 LEU A 273
VAL A 281
HIS A 384
LEU A 393
 H8H  A 534 (-3.8A)
H8H  A 534 (-4.4A)
None
H8H  A 534 (-4.5A)
 0.49A 4qrcA-2h8hA:
30.1		 4qrcA-2h8hA:
25.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hck HEMATOPOETIC CELL
KINASE HCK

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		4 LEU A 273
VAL A 281
HIS A 384
LEU A 393
 QUE  A   1 (-3.9A)
QUE  A   1 ( 4.8A)
None
QUE  A   1 (-4.4A)
 0.61A 4qrcA-2hckA:
29.6		 4qrcA-2hckA:
30.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2huo INOSITOL OXYGENASE

(Mus musculus) 		PF05153
(MIOX) 		4 LEU A 267
VAL A 264
ALA A 103
LEU A 121
 None
 0.82A 4qrcA-2huoA:
undetectable		 4qrcA-2huoA:
24.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hw6 MAP
KINASE-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  55
VAL A  63
HIS A 168
LEU A 177
 None
 0.39A 4qrcA-2hw6A:
13.1		 4qrcA-2hw6A:
22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hw6 MAP
KINASE-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  55
VAL A  63
LYS A  78
LEU A 177
 None
 0.54A 4qrcA-2hw6A:
13.1		 4qrcA-2hw6A:
22.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU A 248
VAL A 256
HIS A 361
LEU A 370
 GIN  A 600 ( 4.6A)
GIN  A 600 ( 4.7A)
GIN  A 600 (-4.3A)
GIN  A 600 (-4.7A)
 0.58A 4qrcA-2hz0A:
31.7		 4qrcA-2hz0A:
40.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2icu HYPOTHETICAL PROTEIN
YEDK

(Escherichia
coli) 		PF02586
(SRAP) 		4 ILE A 138
ALA A  83
LEU A 153
ARG A 145
 None
 0.72A 4qrcA-2icuA:
undetectable		 4qrcA-2icuA:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iwi SERINE/THREONINE-PRO
TEIN KINASE PIM-2

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  38
VAL A  46
ALA A 122
HIS A 161
LEU A 170
 HB1  A1289 ( 4.1A)
HB1  A1289 (-3.6A)
HB1  A1289 ( 4.4A)
None
HB1  A1289 (-4.7A)
 1.19A 4qrcA-2iwiA:
22.0		 4qrcA-2iwiA:
28.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iwi SERINE/THREONINE-PRO
TEIN KINASE PIM-2

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  38
VAL A  46
ILE A 100
HIS A 161
LEU A 170
 HB1  A1289 ( 4.1A)
HB1  A1289 (-3.6A)
HB1  A1289 (-4.1A)
None
HB1  A1289 (-4.7A)
 0.70A 4qrcA-2iwiA:
22.0		 4qrcA-2iwiA:
28.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j0j FOCAL ADHESION
KINASE 1

(Gallus gallus) 		PF00373
(FERM_M)
PF07714
(Pkinase_Tyr) 		4 VAL A 436
LYS A 454
HIS A 544
LEU A 553
 4ST  A1687 ( 4.8A)
4ST  A1687 (-3.4A)
None
4ST  A1687 (-4.4A)
 0.52A 4qrcA-2j0jA:
33.1		 4qrcA-2j0jA:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jam CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE TYPE 1G

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  29
VAL A  37
LYS A  52
LEU A 151
 J60  A1305 (-3.9A)
J60  A1305 (-4.8A)
EDO  A1304 ( 2.9A)
None
 0.82A 4qrcA-2jamA:
19.4		 4qrcA-2jamA:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2m1h TRANSCRIPTION
ELONGATION FACTOR
S-II

(Trypanosoma
brucei) 		PF00855
(PWWP) 		4 VAL A  65
ILE A  72
ALA A  25
LEU A  15
 None
 0.83A 4qrcA-2m1hA:
undetectable		 4qrcA-2m1hA:
16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nad NAD-DEPENDENT
FORMATE
DEHYDROGENASE

(Pseudomonas sp.
101) 		PF00389
(2-Hacid_dh)
PF02826
(2-Hacid_dh_C) 		4 LEU A 233
VAL A 229
ALA A 205
HIS A 379
 None
None
None
NAD  A 394 ( 4.9A)
 0.85A 4qrcA-2nadA:
undetectable		 4qrcA-2nadA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nn6 POLYMYOSITIS/SCLEROD
ERMA AUTOANTIGEN 1

(Homo sapiens) 		PF01138
(RNase_PH)
PF03725
(RNase_PH_C) 		4 LYS A 257
ILE A  35
ALA A 148
LEU A  50
 None
 0.62A 4qrcA-2nn6A:
undetectable		 4qrcA-2nn6A:
24.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ogv MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR
PRECURSOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU A 588
VAL A 596
HIS A 776
LEU A 785
 None
 0.62A 4qrcA-2ogvA:
33.3		 4qrcA-2ogvA:
45.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozg GCN5-RELATED
N-ACETYLTRANSFERASE

(Trichormus
variabilis) 		PF13527
(Acetyltransf_9)
PF13530
(SCP2_2) 		4 LEU A 327
VAL A 336
ILE A 289
LEU A 351
 None
 0.78A 4qrcA-2ozgA:
undetectable		 4qrcA-2ozgA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozo TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		5 LEU A 344
VAL A 352
ALA A 417
HIS A 459
LEU A 468
 ANP  A 615 (-4.4A)
ANP  A 615 (-4.5A)
ANP  A 615 (-3.9A)
None
ANP  A 615 (-4.7A)
 1.02A 4qrcA-2ozoA:
28.1		 4qrcA-2ozoA:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p0o HYPOTHETICAL PROTEIN
DUF871

(Enterococcus
faecalis) 		PF05913
(DUF871) 		4 LEU A  88
VAL A  90
ILE A  67
ALA A  75
 None
 0.85A 4qrcA-2p0oA:
undetectable		 4qrcA-2p0oA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p3g MAP KINASE-ACTIVATED
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU X  70
VAL X  78
LYS X  93
HIS X 184
LEU X 193
 F10  X 401 (-3.9A)
None
F10  X 401 (-4.3A)
None
F10  X 401 ( 4.4A)
 1.16A 4qrcA-2p3gX:
12.3		 4qrcA-2p3gX:
26.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2p4i ANGIOPOIETIN-1
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 838
LYS A 855
ALA A 905
HIS A 962
LEU A 971
 MR9  A 301 (-4.6A)
MR9  A 301 ( 4.6A)
MR9  A 301 (-3.6A)
MR9  A 301 (-4.5A)
MR9  A 301 (-4.5A)
 0.82A 4qrcA-2p4iA:
27.9		 4qrcA-2p4iA:
43.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2p4i ANGIOPOIETIN-1
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 838
LYS A 855
ILE A 886
HIS A 962
LEU A 971
 MR9  A 301 (-4.6A)
MR9  A 301 ( 4.6A)
MR9  A 301 (-4.0A)
MR9  A 301 (-4.5A)
MR9  A 301 (-4.5A)
 1.11A 4qrcA-2p4iA:
27.9		 4qrcA-2p4iA:
43.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p9j HYPOTHETICAL PROTEIN
AQ2171

(Aquifex
aeolicus) 		PF08282
(Hydrolase_3) 		4 LEU A  73
VAL A  75
ILE A  16
LEU A  20
 None
 0.78A 4qrcA-2p9jA:
undetectable		 4qrcA-2p9jA:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pge MENC

(Desulfotalea
psychrophila) 		PF13378
(MR_MLE_C) 		4 LEU A 107
VAL A 112
ALA A 128
LEU A  37
 None
 0.75A 4qrcA-2pgeA:
undetectable		 4qrcA-2pgeA:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2phk PHOSPHORYLASE KINASE

(Oryctolagus
cuniculus) 		PF00069
(Pkinase) 		5 LEU A  25
VAL A  33
ILE A  87
HIS A 147
LEU A 156
 ATP  A 381 ( 4.3A)
ATP  A 381 (-4.1A)
None
None
ATP  A 381 ( 4.8A)
 0.70A 4qrcA-2phkA:
22.9		 4qrcA-2phkA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2phk PHOSPHORYLASE KINASE

(Oryctolagus
cuniculus) 		PF00069
(Pkinase) 		5 LEU A  25
VAL A  33
LYS A  48
ILE A  87
LEU A 156
 ATP  A 381 ( 4.3A)
ATP  A 381 (-4.1A)
ATP  A 381 (-3.2A)
None
ATP  A 381 ( 4.8A)
 0.81A 4qrcA-2phkA:
22.9		 4qrcA-2phkA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pmo SER/THR PROTEIN
KINASE

(Plasmodium
falciparum) 		PF00069
(Pkinase) 		4 LEU X  34
LYS X  55
HIS X 170
LEU X 179
 HMD  X 400 ( 4.3A)
HMD  X 400 (-4.2A)
None
HMD  X 400 (-4.7A)
 0.80A 4qrcA-2pmoX:
21.6		 4qrcA-2pmoX:
21.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2psq FIBROBLAST GROWTH
FACTOR RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 LEU A 487
VAL A 495
ILE A 548
ALA A 567
HIS A 624
LEU A 633
 None
 0.56A 4qrcA-2psqA:
36.4		 4qrcA-2psqA:
66.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qo3 ERYAII ERYTHROMYCIN
POLYKETIDE SYNTHASE
MODULES 3 AND 4

(Saccharopolyspora
erythraea) 		PF00109
(ketoacyl-synt)
PF00698
(Acyl_transf_1)
PF02801
(Ketoacyl-synt_C)
PF16197
(KAsynt_C_assoc) 		4 LEU A 509
VAL A 505
ALA A 488
LEU A 534
 None
 0.86A 4qrcA-2qo3A:
undetectable		 4qrcA-2qo3A:
17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qp4 BILE SALT
SULFOTRANSFERASE

(Homo sapiens) 		PF00685
(Sulfotransfer_1) 		4 LEU A  95
VAL A  37
LYS A 115
ILE A 198
 None
 0.84A 4qrcA-2qp4A:
undetectable		 4qrcA-2qp4A:
19.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2r4b RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-4

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU A 724
VAL A 732
HIS A 841
LEU A 850
 GW7  A   1 ( 4.2A)
GW7  A   1 ( 4.8A)
None
GW7  A   1 (-4.2A)
 0.43A 4qrcA-2r4bA:
29.8		 4qrcA-2r4bA:
36.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vd5 DMPK PROTEIN

(Homo sapiens) 		PF00069
(Pkinase) 		4 VAL A  85
LYS A 100
HIS A 193
LEU A 202
 BI8  A1417 ( 4.7A)
BI8  A1417 (-4.2A)
None
BI8  A1417 (-4.8A)
 0.63A 4qrcA-2vd5A:
20.7		 4qrcA-2vd5A:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vgi PYRUVATE KINASE
ISOZYMES R/L

(Homo sapiens) 		PF00224
(PK)
PF02887
(PK_C) 		4 LEU A 236
VAL A 185
ILE A 162
LEU A 254
 None
 0.86A 4qrcA-2vgiA:
undetectable		 4qrcA-2vgiA:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vml PHYCOCYANIN ALPHA
CHAIN

(Gloeobacter
violaceus) 		PF00502
(Phycobilisome) 		4 LEU A 142
VAL A 138
ALA A  41
LEU A  97
 None
 0.86A 4qrcA-2vmlA:
undetectable		 4qrcA-2vmlA:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vmx SERINE
HYDROXYMETHYLTRANSFE
RASE

(Geobacillus
stearothermophilus) 		PF00464
(SHMT) 		4 LEU A  28
VAL A 338
ALA A 377
LEU A 296
 None
 0.75A 4qrcA-2vmxA:
undetectable		 4qrcA-2vmxA:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vuw SERINE/THREONINE-PRO
TEIN KINASE HASPIN

(Homo sapiens) 		PF12330
(Haspin_kinase) 		4 VAL A 498
ILE A 557
HIS A 647
LEU A 656
 5ID  A1800 ( 4.5A)
5ID  A1800 ( 4.5A)
None
5ID  A1800 (-4.5A)
 0.58A 4qrcA-2vuwA:
undetectable		 4qrcA-2vuwA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vuw SERINE/THREONINE-PRO
TEIN KINASE HASPIN

(Homo sapiens) 		PF12330
(Haspin_kinase) 		4 VAL A 498
LYS A 511
ILE A 557
LEU A 656
 5ID  A1800 ( 4.5A)
IOD  A1799 (-3.2A)
5ID  A1800 ( 4.5A)
5ID  A1800 (-4.5A)
 0.80A 4qrcA-2vuwA:
undetectable		 4qrcA-2vuwA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w4o CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE TYPE IV

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  52
VAL A  60
ILE A 102
HIS A 162
LEU A 171
 DKI  A1338 (-3.8A)
DKI  A1338 (-4.2A)
DKI  A1338 ( 4.4A)
None
DKI  A1338 (-4.9A)
 0.86A 4qrcA-2w4oA:
21.3		 4qrcA-2w4oA:
28.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w4o CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE TYPE IV

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  52
VAL A  60
LYS A  75
ILE A 102
LEU A 171
 DKI  A1338 (-3.8A)
DKI  A1338 (-4.2A)
None
DKI  A1338 ( 4.4A)
DKI  A1338 (-4.9A)
 0.76A 4qrcA-2w4oA:
21.3		 4qrcA-2w4oA:
28.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2whx SERINE
PROTEASE/NTPASE/HELI
CASE NS3

(Dengue virus) 		PF00949
(Peptidase_S7)
PF07652
(Flavi_DEAD) 		4 LEU A 128
VAL A 126
ALA A  99
HIS A  51
 None
 0.86A 4qrcA-2whxA:
undetectable		 4qrcA-2whxA:
21.86